OB/GYN Clinical Alert – June 1, 2008
June 1, 2008
View Issues
-
Duration of Lactation is Associated with Lower Prevalence of the Metabolic Syndrome in Midlife — SWAN, the Study of Women's Health Across the Nation
The SWAN is a multisite, multi ethnic, prospective, observational, longitudinal study of 3302 women who were enrolled between 1995-1997. -
What is the Role of the Gynecologist in Providing Preventive Services?
The authors set out to determine the preventive services and counseling provided by gynecologists, general medical physicians, or both. Using the 2000 National Health Interview Survey, the study population included women aged 18-64 years of age (with regard to Pap smear, use of tobacco, and exercise/diet counseling) and women in the 50-64 age group (previous parameters plus breast examinations, mammograms, and colon cancer screening). Sixty-two percent of patients were seen by gynecologists, 15% by general medical physicians, and 23% by both. -
Side Effects with Aromatase Inhibitors
Cuppone and colleagues primarily from the Regina Elena National Cancer Institute in Rome, Italy, performed a meta-analysis of randomized trials comparing aromatase inhibitors with tamoxifen in early breast cancer, focusing on cardiovascular risk. -
HABITS Redux
HABITS was a randomized but not placebo-controlled trial in which hormone therapy was compared to management without hormones in women with menopausal symptoms who had been previously treated for Stage I or Stage II breast cancer.1 Concomitant tamoxifen treatment was allowed in the HABITS patients but not aromatase inhibiters. -
How Safe is Acetaminophen and Pregnancy?
Being pregnant puts patients in a special category where, seemingly, everything they put in their mouths, even some foods, has some risk to the fetus. -
Leisure Time Physical Activity is Associated with a Reduced Risk of Preterm Delivery
Many pregnant patients ask whether it is bad to exercise regularly and vigorously, while others ask whether exercising in any way helps to improve outcome. These questions were addressed in a recent publication in the American Journal of Obstetrics & Gynecology. -
Pharmacology Watch: New Study on Thiazolidinediones May Show Benefits
In this Issue: Pioglitazone and heart disease; ARBs manufacturers spend millions to show the non-inferiority of their products compared to less expensive, generic ACE inhibitors; some athletes turn to growth hormone because it is difficult to detect; FDA Actions -
Clinical Briefs in Primary Care supplement